Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA polymerase II associated protein 2 pseudogene 1 (RPAP2P1) is a predicted pseudogene in the human genome. Pseudogenes resemble protein-coding genes but are generally considered non-functional due to mutations or lack of regulatory elements. There is no evidence that RPAP2P1 encodes a functional protein, nor that it is involved in any biological pathways, disease processes, or functions as a therapeutic target. It is distinct from the protein-coding gene RNA polymerase II associated protein 2 (RPAP2), which participates in RNA polymerase II biogenesis and nuclear import, but RPAP2P1 itself has no known functional or clinical relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA polymerase II associated protein 2 pseudogene 1 (RPAP2P1).